2-amino-6-chloro-3,4-dihydroquinazoline Hydrochloride (2) is 5-HT3 receptor antagonist. The results viewed that monosubstitution and di-substitution of terminal amine lead to abolish binding affinity at 5-HT3 receptors and this was consistent with molecular docking studies. Even quternization showed reduction in affinity.
